Actively Recruiting
Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity
Led by Vanderbilt University Medical Center · Updated on 2025-05-15
90
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
Sponsors
V
Vanderbilt University Medical Center
Lead Sponsor
N
National Institutes of Health (NIH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this proposal is to develop novel HH-SECTR technology for visualizing and quantifying diagnostic disease features in prematurely born infant retinopathy of prematurity (ROP) patients that lead to more informed clinical decision making. Providing depth-resolved vascular information has not been adequately investigated for its diagnostic potential. Furthermore, we seek to identify disease features not currently accessible by standard examination methods to better inform clinical decisions.
CONDITIONS
Official Title
Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Preterm male and female infants born at 24-34 weeks gestational age and weighing <1500g at birth
You will not qualify if you...
- Infants surgically treated for ROP
- Infants with significant health concern that would preclude noninvasive retinal imaging as noted by the primary inpatient team
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232
Actively Recruiting
Research Team
I
Irina De la Huerta, MD, PhD
CONTACT
M
Marybeth Carter
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here